{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:13:28Z","timestamp":1778566408430,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022965","name":"Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["RC 946-2019"],"award-info":[{"award-number":["RC 946-2019"]}],"id":[{"id":"10.13039\/100022965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022965","name":"Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["111584467189"],"award-info":[{"award-number":["111584467189"]}],"id":[{"id":"10.13039\/100022965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001721","name":"Rijksuniversiteit Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005278","name":"University of Antioquia","doi-asserted-by":"publisher","award":["2024\\u201366871"],"award-info":[{"award-number":["2024\\u201366871"]}],"id":[{"id":"10.13039\/501100005278","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mnisterio de Ciencia, Tecnologia e Innovaci\u00f3n - MinCiencias"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bbamem.2025.184429","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T02:29:43Z","timestamp":1749263383000},"page":"184429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Crotalicidin and NA-CATH-ATRA-1-ATRA-1 peptide-induced membrane disruption in human breast cancer cells"],"prefix":"10.1016","volume":"1867","author":[{"given":"Vanessa","family":"Gallego-Londo\u00f1o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria A.","family":"Santa-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan M.","family":"Giraldo-Lorza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Bea A.","family":"Wisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Manrique-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamem.2025.184429_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbamem.2025.184429_bb0010","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1002\/cncr.32887","article-title":"Breast cancer early detection: a phased approach to implementation","volume":"126","author":"Ginsburg","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.bbamem.2025.184429_bb0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.bbamem.2025.184429_bb0020","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.ajpath.2017.04.022","article-title":"Breast cancer molecular stratification: from intrinsic subtypes to integrative clusters","volume":"187","author":"Russnes","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbamem.2025.184429_bb0025","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.3390\/cancers12113271","article-title":"Breast cancer heterogeneity and response to novel therapeutics","volume":"12","author":"Baliu-Piqu\u00e9","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbamem.2025.184429_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2017.00227","article-title":"Tumor heterogeneity in breast cancer","volume":"4","author":"Turashvili","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.bbamem.2025.184429_bb0035","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cpet.2018.02.006","article-title":"Overview of breast cancer therapy","volume":"13","author":"Moo","year":"2018","journal-title":"PET Clinics"},{"key":"10.1016\/j.bbamem.2025.184429_bb0040","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1200\/JCO.19.03120","article-title":"Management of male breast cancer: ASCO guideline","volume":"38","author":"Hassett","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbamem.2025.184429_bb0045","series-title":"Chemosensitivity: Volume II: In Vivo Models, Imaging, and Molecular Regulators","first-page":"127","article-title":"Overview of tumor cell chemoresistance mechanisms","author":"Gatti","year":"2005"},{"key":"10.1016\/j.bbamem.2025.184429_bb0050","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of cancer drug resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbamem.2025.184429_bb0055","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41429-018-0050-2","article-title":"Effect of antimicrobial peptides from Galleria mellonella on molecular models of Leishmania membrane. Thermotropic and fluorescence anisotropy study","volume":"71","author":"Pati\u00f1o-M\u00e1rquez","year":"2018","journal-title":"J. Antibiot."},{"key":"10.1016\/j.bbamem.2025.184429_bb0060","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1089\/sur.2018.194","article-title":"Antimicrobial peptides","volume":"19","author":"Fry","year":"2018","journal-title":"Surg. Infect. (Larchmt.)"},{"key":"10.1016\/j.bbamem.2025.184429_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.55.1.2","article-title":"Mechanisms of antimicrobial peptide action and resistance","volume":"55","author":"Yeaman","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbamem.2025.184429_bb0070","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s10989-019-09946-9","article-title":"Antimicrobial peptides (AMPs): roles, functions and mechanism of action","volume":"26","author":"Seyfi","year":"2020","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.bbamem.2025.184429_bb0075","doi-asserted-by":"crossref","first-page":"12732","DOI":"10.3390\/ijms232112732","article-title":"Antimicrobial peptides mediate apoptosis by changing mitochondrial membrane permeability","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbamem.2025.184429_bb0080","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bbamem.2007.11.008","article-title":"Studies on anticancer activities of antimicrobial peptides","volume":"1778","author":"Hoskin","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2025.184429_bb0085","doi-asserted-by":"crossref","first-page":"34910","DOI":"10.18632\/oncotarget.5308","article-title":"The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells","volume":"6","author":"Eike","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbamem.2025.184429_bb0090","author":"National Library of Medicine"},{"key":"10.1016\/j.bbamem.2025.184429_bb0095","series-title":"Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide","author":"Haug","year":"2016"},{"key":"10.1016\/j.bbamem.2025.184429_bb0100","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1338236","article-title":"Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model","volume":"6","author":"Nestvold","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbamem.2025.184429_bb0105","series-title":"1051P Intratumoral Injection of LTX-315 in Combination with Pembrolizumab in Patients with Advanced Melanoma Refractory to Prior PD-1\/PD-L1 Therapy: Interim Results from the ATLAS-IT-05 Trial","first-page":"S636","volume":"34","author":"Dalle","year":"2023"},{"key":"10.1016\/j.bbamem.2025.184429_bb0110","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/toxins10110474","article-title":"Snake venom peptides: tools of biodiscovery","volume":"10","author":"Munawar","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.bbamem.2025.184429_bb0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/1570164611310010003","article-title":"Snake venom proteins and peptides as novel antibiotics against microbial infections","volume":"10","author":"Samy","year":"2013","journal-title":"Curr. Proteomics"},{"key":"10.1016\/j.bbamem.2025.184429_bb0120","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1007\/s00726-014-1801-4","article-title":"Vipericidins: a novel family of cathelicidin-related peptides from the venom gland of South American pit vipers","volume":"46","author":"Falcao","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbamem.2025.184429_bb0125","doi-asserted-by":"crossref","first-page":"8553","DOI":"10.1021\/acs.jmedchem.5b01142","article-title":"Structural dissection of crotalicidin, a rattlesnake venom cathelicidin, retrieves a fragment with antimicrobial and antitumor activity","volume":"58","author":"Falcao","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbamem.2025.184429_bb0130","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1074\/jbc.RA117.000125","article-title":"Mechanisms of bacterial membrane permeabilization by crotalicidin (Ctn) and its fragment Ctn (15\u201334), antimicrobial peptides from rattlesnake venom","volume":"293","author":"P\u00e9rez-Peinado","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2025.184429_bb0135","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.peptides.2008.06.008","article-title":"Identification and characterization of novel reptile cathelicidins from elapid snakes","volume":"29","author":"Zhao","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.bbamem.2025.184429_bb0140","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.bbrc.2010.04.158","article-title":"Antimicrobial activity of the Naja atra cathelicidin and related small peptides","volume":"396","author":"de Latour","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamem.2025.184429_bb0145","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1471-2180-11-114","article-title":"Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus","volume":"11","author":"Dean","year":"2011","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.bbamem.2025.184429_bb0150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/ja.2016.135","article-title":"Anti-fungal activity of Ctn [15\u201334], the C-terminal peptide fragment of crotalicidin, a rattlesnake venom gland cathelicidin","volume":"70","author":"Cavalcante","year":"2017","journal-title":"J. Antibiot."},{"key":"10.1016\/j.bbamem.2025.184429_bb0155","series-title":"Handbook of Molecular and Cellular Methods in Biology and Medicine","author":"Cseke","year":"2011"},{"key":"10.1016\/j.bbamem.2025.184429_bb0160","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3390\/membranes12050534","article-title":"Infrared spectroscopic study of multi-component lipid systems: a closer approximation to biological membrane fluidity","volume":"12","author":"Klaiss-Luna","year":"2022","journal-title":"Membranes"},{"key":"10.1016\/j.bbamem.2025.184429_bb0165","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1021\/ol030084r","article-title":"Sugar\/steroid\/sugar conjugates: sensitivity of lipid binding to sugar structure","volume":"5","author":"Mbadugha","year":"2003","journal-title":"Org. Lett."},{"key":"10.1016\/j.bbamem.2025.184429_bb0170","series-title":"Adv Exp Med Biol","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-4419-6199-0_9","article-title":"Analysis of cellular DNA content by flow and laser scanning cytometry","author":"Darzynkiewicz","year":"2010"},{"key":"10.1016\/j.bbamem.2025.184429_bb0175","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0076-6879(08)01606-6","article-title":"DNA damage response and apoptosis","volume":"446","author":"Plesca","year":"2008","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbamem.2025.184429_bb0180","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10495-012-0756-8","article-title":"Necrosis-like death can engage multiple pro-apoptotic Bcl-2 protein family members","volume":"17","author":"Tischner","year":"2012","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbamem.2025.184429_bb0185","doi-asserted-by":"crossref","first-page":"20823","DOI":"10.1038\/srep20823","article-title":"PFR peptide, one of the antimicrobial peptides identified from the derivatives of lactoferrin, induces necrosis in leukemia cells","volume":"6","author":"Lu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamem.2025.184429_bb0190","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1080\/15384101.2015.1093710","article-title":"The oncolytic peptide LTX-315 triggers necrotic cell death","volume":"14","author":"Forveille","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbamem.2025.184429_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201220","article-title":"The anticancer peptide RT53 induces immunogenic cell death","volume":"13","author":"Pasquereau-Kotula","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.bbamem.2025.184429_bb0200","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.cdd.4401231","article-title":"Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis","volume":"10","author":"Gottlieb","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbamem.2025.184429_bb0205","series-title":"Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents)","first-page":"2048","article-title":"Role of mitochondrial membrane potential and lactate dehydrogenase a in apoptosis","volume":"22","author":"Zaib","year":"2022"},{"key":"10.1016\/j.bbamem.2025.184429_bb0210","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.7150\/jca.18457","article-title":"Breast cancer cell line classification and its relevance with breast tumor subtyping","volume":"8","author":"Dai","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbamem.2025.184429_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044351","article-title":"Antitumor and angiostatic activities of the antimicrobial peptide dermaseptin B2","volume":"7","author":"van Zoggel","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.bbamem.2025.184429_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-11-116","article-title":"Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells","volume":"11","author":"Fadnes","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbamem.2025.184429_bb0225","doi-asserted-by":"crossref","first-page":"26599","DOI":"10.18632\/oncotarget.5613","article-title":"The oncolytic peptide LTX-315 kills cancer cells through Bax\/Bak-regulated mitochondrial membrane permeabilization","volume":"6","author":"Zhou","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbamem.2025.184429_bb0230","doi-asserted-by":"crossref","first-page":"348","DOI":"10.15698\/cst2019.11.204","article-title":"LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects","volume":"3","author":"Liao","year":"2019","journal-title":"Cell Stress"},{"key":"10.1016\/j.bbamem.2025.184429_bb0235","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1158\/1078-0432.CCR-20-3435","article-title":"Safety, antitumor activity, and T-cell responses in a dose-ranging phase I trial of the oncolytic peptide LTX-315 in patients with solid tumors","volume":"27","author":"Spicer","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbamem.2025.184429_bb0240","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.trecan.2020.12.012","article-title":"Targeting cancer heterogeneity with immune responses driven by oncolytic peptides","volume":"7","author":"Vitale","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbamem.2025.184429_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216226","article-title":"Biophysical insights into the antitumoral activity of crotalicidin against breast cancer model membranes","volume":"24","author":"Klaiss-Luna","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbamem.2025.184429_bb0250","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.chembiol.2016.12.009","article-title":"Glycan alteration imparts cellular resistance to a membrane-lytic anticancer peptide","volume":"24","author":"Ishikawa","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.bbamem.2025.184429_bb0255","first-page":"1365","article-title":"Differential expression of the \u03b12, 3-sialic acid residues in breast cancer is associated with metastatic potential","volume":"25","author":"Cui","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbamem.2025.184429_bb0260","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00018-014-1741-x","article-title":"Immunogenicity of necrotic cell death","volume":"72","author":"Gamrekelashvili","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbamem.2025.184429_bb0265","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.47","article-title":"The oncolytic peptide LTX-315 triggers immunogenic cell death","volume":"7","author":"Zhou","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbamem.2025.184429_bb0270","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005273625000239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005273625000239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:37:21Z","timestamp":1778564241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0005273625000239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":54,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0005273625000239"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamem.2025.184429","relation":{},"ISSN":["0005-2736"],"issn-type":[{"value":"0005-2736","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crotalicidin and NA-CATH-ATRA-1-ATRA-1 peptide-induced membrane disruption in human breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Biomembranes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamem.2025.184429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"184429"}}